The CHI operates in three modes: collaborative scientific studies, scientific technology development, and technology partnerships. Collaborative studies aim to leverage the high-dimensional technologies and expertise available in the CHI to enable systems-level characterization of immune phenotypes. Collaborative studies will be selected competitively from a call for proposal which is announced multiple times per year. Scientific study proposals can also be selected as a technology development project if the aims of the proposal don't match the criteria to be selected as a collaborative scientific study. Alternatively, a subset of the technologies at CHI are available to any NIH users through the CHI Technology Partnership Program (TPP) where CHI can generate data for a fee to cover costs, but study design and data analysis are the responsibility of the customer.